KR950701317A - Indole Derivative - Google Patents

Indole Derivative

Info

Publication number
KR950701317A
KR950701317A KR1019940704000A KR19940704000A KR950701317A KR 950701317 A KR950701317 A KR 950701317A KR 1019940704000 A KR1019940704000 A KR 1019940704000A KR 19940704000 A KR19940704000 A KR 19940704000A KR 950701317 A KR950701317 A KR 950701317A
Authority
KR
South Korea
Prior art keywords
group
lower alkyl
phenyl
alkyl group
optionally
Prior art date
Application number
KR1019940704000A
Other languages
Korean (ko)
Inventor
마사또시 이나이
다다나오 시부따니
준 가나야
마사꼬 모리따께
아끼에 다나까
Original Assignee
오오쓰까 아끼히꼬
가부시끼가이샤 오오쓰까세이야꾸 고우죠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오오쓰까 아끼히꼬, 가부시끼가이샤 오오쓰까세이야꾸 고우죠 filed Critical 오오쓰까 아끼히꼬
Publication of KR950701317A publication Critical patent/KR950701317A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

본 발명은 하기 일반식의 인돌 유도체를 제공한다 :The present invention provides indole derivatives of the general formula:

본 발명의 인돌 유도체는 강력한 항에스트로젠 활성을 가지며, 무배란성 불임증, 전립선 비대증, 골다공증, 유방암, 자궁내막암 및 흑색종과 같은 에스트로젠성 질병의 치료용 약제로서 유용하다.Indole derivatives of the present invention have potent antiestrogens activity and are useful as agents for the treatment of estrogen diseases such as ovulation infertility, prostate hyperplasia, osteoporosis, breast cancer, endometrial cancer and melanoma.

Description

인돌 유도체(Indole Derivative)Indole Derivative

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (8)

하기 일반식의 인돌 유도체 :Indole derivatives of the general formula: [식중, R1은 할로겐 원자이고, R2는 수소원자, 저급 알킬기, 저급 알카노일기 또는 벤조일기이고, R3는 수소원자, 저급 알킬기 또는 할로겐 원자이고, R4는 티에닐기 또는 일반식[Wherein, R 1 is a halogen atom, R 2 is a hydrogen atom, a lower alkyl group, a lower alkanoyl group or a benzoyl group, R 3 is a hydrogen atom, a lower alkyl group or a halogen atom, and R 4 is a thienyl group or a general formula (식중, R6는 저급 알킬기, 시클로알킬기, 치환체로서 임의로 저급 알킬기를 가질 수 있는 페닐기, 페닐-저급 알킬기 또는 피리딜기이고, R7은 수소원자 또는 저급 알킬기이고, Q는 황 또는 셀레늄 원자이며 n은 0~2의 정수이다)의 기이고, A는 알킬렌기이고, m은 0~1의 정수이고, R5는, m이 0일 경우, 수소원자, 알킬기, 또는 치환체로서 히드록실기 또는 일반식 -O-B-R8(식중, B는 저급 알킬렌기이고 R8은 페닐, 디-저급 알킬-아미노, 1-피롤리디닐, 피페리디노, 1-이미다졸릴 또는 1, 2, 4-트리아졸-1-일기이다)의 기를 갖는 벤조일기이거나, m이 1일 경우 R5는 저급 알콕시카르보닐기, 카르복실기, 히드록실기, 일반식 -C(=O)-N(R9)-R10(식중, R9및 R10은 동일하거나 상이하며 각각 수소원자, 저급 알킬기, 벤젠고리가 임의로 융합 또는 축합 될 수 있는 시클로알킬기, 페닐기, 페닐-저급 알킬기 또는 저급 알킬술포닐기이거나, R9및 R10은 직접 또는 산소 또는 황원자를 통해 서로 결합하여, 인접 질소원자와 함께, 저급 알콕시카르보닐 또는 카르복실기로 임의로 치환될 수 있는 헤테로고리기를 형성한다)의 기, 일반식 -CH2-N(R11)-R12(식중, R11및 R12는 동일하거나 상이하며 각각 수소원자, 저급 알킬기, 축합된 벤젠고리를 임의로 가질 수 있는 시클로알킬기, 페닐기, 페닐 저급 알킬기 또는 저급 알카노일기이거나, R11및 R12는 직접 또는 산소 또는 황원자를 통해 서로 결합하여, 인접 질소 원자와 함께, 저급 알콕시카르보닐 또는 카르복실기로 임의로 치환될 수 있는 헤테로고리기를 형성한다)의 기, 일반식 -OR13(식중, R13은 저급 알킬카르바모일페닐기, 저급 알킬아미노메틸페닐기, 저급 알킬아미노메틸페닐기, 1-피롤리디닐카르보닐페닐기, 1-피롤리디닐메틸페닐기, 2-디-저급 알킬아미노에틸기 또는 2-히드록시-2-저급 알킬아미노에틸기이다)의 기 또는 치환체로서 임의로 히드록실기, 저급 알콕시기, 1-피롤리디닐카르보닐 또는 1-피롤리디닐메틸기를 가질 수 있는 페닐기이고, x는 0~2의 정수이다.]Wherein R 6 is a lower alkyl group, a cycloalkyl group, a phenyl group which may optionally have a lower alkyl group as a substituent, a phenyl-lower alkyl group or a pyridyl group, R 7 is a hydrogen atom or a lower alkyl group, Q is a sulfur or selenium atom and n is a group of an integer of 0 ~ 2), a is an alkylene group, m is an integer of 0 ~ 1, R 5 is, m is 0, as a hydrogen atom, an alkyl group, or a substituent hydroxyl group or general Formula -OBR 8 wherein B is a lower alkylene group and R 8 is phenyl, di-lower alkyl-amino, 1-pyrrolidinyl, piperidino, 1-imidazolyl or 1, 2, 4-triazole- R 5 is a lower alkoxycarbonyl group, carboxyl group, hydroxyl group, general formula -C (= O) -N (R 9 ) -R 10 (wherein R 9 and R 10 are the same or different and are each a hydrogen atom, a lower alkyl group, a cycloalkyl group with a benzene ring may be fused or fused, optionally, Group, a phenyl-or a lower alkyl group or a lower alkylsulfonyl group, R 9 and R 10 directly or in combination with each other via an oxygen or sulfur atom, together with the adjacent nitrogen atom, lower alkoxycarbonyl or heterocyclic ring which may be optionally substituted with a carboxyl group A group of formula -CH 2 -N (R 11 ) -R 12 , wherein R 11 and R 12 are the same or different and may each optionally have a hydrogen atom, a lower alkyl group and a condensed benzene ring Or a cycloalkyl group, a phenyl group, a phenyl lower alkyl group or a lower alkanoyl group, or R 11 and R 12 may be directly substituted with each other directly or through an oxygen or sulfur atom and optionally substituted with a lower alkoxycarbonyl or carboxyl group with adjacent nitrogen atoms. Group of the heterocyclic group, general formula -OR 13 (wherein R 13 is a lower alkylcarbamoylphenyl group, a lower alkylaminomethylphenyl group, a lower alkylaminomethylphenyl group, Optionally a hydroxyl group, a lower group as a group or a substituent of 1-pyrrolidinylcarbonylphenyl group, 1-pyrrolidinylmethylphenyl group, 2-di-lower alkylaminoethyl group or 2-hydroxy-2-lower alkylaminoethyl group) Is a phenyl group which may have an alkoxy group, 1-pyrrolidinylcarbonyl or 1-pyrrolidinylmethyl group, and x is an integer of 0 to 2]. 제1항에 있어서, R2가 수소원자이고, R3가 수소원자 또는 저급 알킬기이며, R4가 일반식The compound of claim 1, wherein R 2 is a hydrogen atom, R 3 is a hydrogen atom or a lower alkyl group, and R 4 is a general formula 식중, R6는 저급알킬기, 시클로알킬기, 치환체로서 1 이상의 저급알킬기를 임의로 가질 수 있는 페닐기, 페닐-저급 알킬기 또는 피리딜기이다)의 기이고, m이 1인 인돌 유도체.Wherein R 6 is a lower alkyl group, a cycloalkyl group, a group of a phenyl group, a phenyl-lower alkyl group or a pyridyl group which may optionally have one or more lower alkyl groups as substituents, and m is 1; 제2항에 있어서, R5가 일반식 -C(=O)-N(R9)-R10(식중, R9및 R10은 동일하거나 상이하며 각각 수소원자, 저급 알킬기, 벤젠고리가 축합될 수 있는 시클로알킬기, 페닐기, 페닐-저급 알킬기 또는 저급 알킬술포닐기이거나, R9및 R10은 직접 또는 산소 또는 황원자를 통해 서로 결합하여, 인접 질소원자와 함께, 저급 알콕시카르보닐 또는 카르복실기로 임의로 치환될 수 있는 헤테로고리기를 형성한다)의 기, 일반식 -CH2-N(R11)-R12(식중, R11및 R12는 동일하거나 상이하며 각각 수소원자, 저급 알킬기, 벤젠고리가 임의로 축합될 수 있는 시클로알킬기, 페닐기, 페닐 저급 알킬기 또는 저급 알카노일기이거나, R11및 R12는 직접 또는 산소 또는 황원자를 통해 서로 결합하여, 인접 질소 원자와 함께, 저급 알콕시카르보닐 또는 카르복실기로 임의로 치환될 수 있는 헤테로고리기를 형성한다)의 기인 인돌 유도체.3. A compound according to claim 2, wherein R 5 is of the formula -C (= 0) -N (R 9 ) -R 10 wherein R 9 and R 10 are the same or different and each hydrogen atom, lower alkyl group, benzene ring is condensed May be a cycloalkyl group, a phenyl group, a phenyl-lower alkyl group or a lower alkylsulfonyl group, or R 9 and R 10 are bonded to each other directly or through an oxygen or sulfur atom, optionally with a lower alkoxycarbonyl or carboxyl group, with adjacent nitrogen atoms A group of a heterocyclic group which may be substituted, and the general formula —CH 2 —N (R 11 ) —R 12 , wherein R 11 and R 12 are the same or different and each hydrogen atom, lower alkyl group, or benzene ring Is a cycloalkyl group, phenyl group, phenyl lower alkyl group or lower alkanoyl group which may be optionally condensed, or R 11 and R 12 are bonded to each other directly or through an oxygen or sulfur atom, together with a adjacent nitrogen atom, a lower alkoxycarbonyl or carboxyl group To be optionally substituted Heterocyclic group of indole derivatives to form a ring) that. 제1항에 있어서, 하기 일반식의 인돌 유도체 :The indole derivative of claim 1 wherein [식중, R3는 수소원자, 저급 알킬기 또는 할로겐 원자이고, R6는 저급 알킬기, 시클로알킬기, 치환체로서 임의로 1 이상의 저급 알킬기를 가질 수 있는 페닐기, 페닐-저급 알킬기 또는 피리딜기이고, R11및 R12는 동일하거나 상이하며, 각각 수소원자, 저급 알킬기, 벤젠고리가 임의로 축합될 수 있는 시클로알킬기, 페닐기, 페닐-저급 알킬기 또는 저급 알카노일기이거나, R11및 R12가 직접 또는 산소 또는 황원자를 통해 서로 결합하여, 인접 질소원자와 함께, 저급 알콕시카르보닐 또는 카르복실기로 임의로 치환될 수 있는 헤테로고리기를 형성한다.[Wherein R 3 is a hydrogen atom, a lower alkyl group or a halogen atom, R 6 is a lower alkyl group, a cycloalkyl group, a phenyl group which may optionally have one or more lower alkyl groups as substituents, a phenyl-lower alkyl group or a pyridyl group, R 11 and R 12 is the same or different and each is a cycloalkyl group, a phenyl group, a phenyl-lower alkyl group or a lower alkanoyl group in which a hydrogen atom, a lower alkyl group or a benzene ring may be optionally condensed, or R 11 and R 12 are directly or an oxygen or sulfur atom And combine with each other to form a heterocyclic group which may optionally be substituted with a lower alkoxycarbonyl or carboxyl group with adjacent nitrogen atoms. 활성 성분으로서 제1항의 인돌 유도체를 함유하는 에스트로젠 억제제.An estrogen inhibitor containing the indole derivative of claim 1 as an active ingredient. 활성 성분으로서 제3항의 인돌 유도체를 함유하는 에스트로젠 억제제.An estrogen inhibitor containing the indole derivative of claim 3 as an active ingredient. 활성 성분으로서 제4항의 인돌 유도체를 함유하는 에스트로젠 억제제.An estrogen inhibitor containing the indole derivative of claim 4 as an active ingredient. 제5항의 에스트로젠 억제제의 약학적 유효량을 환자에게 투여함을 특징으로 하는 에스트로젠성 질환의 치료방법.A method for treating estrogen disorders, comprising administering to a patient a pharmaceutically effective amount of the estrogen inhibitor of claim 5. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019940704000A 1992-05-08 1993-04-28 Indole Derivative KR950701317A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP92-116126 1992-05-08
JP11612692 1992-05-08
PCT/JP1993/000560 WO1993023374A1 (en) 1992-05-08 1993-04-28 Indole derivative

Publications (1)

Publication Number Publication Date
KR950701317A true KR950701317A (en) 1995-03-23

Family

ID=14679354

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940704000A KR950701317A (en) 1992-05-08 1993-04-28 Indole Derivative

Country Status (7)

Country Link
US (1) US5496844A (en)
EP (1) EP0639567A1 (en)
KR (1) KR950701317A (en)
AU (1) AU665690B2 (en)
CA (1) CA2135160A1 (en)
TW (1) TW239125B (en)
WO (1) WO1993023374A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680740B2 (en) * 1994-02-22 1997-08-07 Merrell Pharmaceuticals Inc. Novel indole derivatives useful to treat estrogen-related neoplasms and disorders
HUP9701714A3 (en) * 1995-09-01 2000-03-28 Lilly Co Eli Indole derivatives neuropeptide y receptor antagonists, use thereof and pharmaceutical compositions containing these compounds
GB9523999D0 (en) 1995-11-23 1996-01-24 Lilly Co Eli Indolyl neuropeptide y receptor antagonists
US5780497A (en) * 1996-04-19 1998-07-14 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
DE69707189T2 (en) * 1996-04-19 2002-06-20 American Home Products Corp., Madison Estrogenic compounds
US5985910A (en) * 1996-04-19 1999-11-16 American Home Products Corporation 3- [4- (2- Phenyl-Indole-1-ylmethyl) Phenyl]- Acrylamides as estrogenic agents
US5880137A (en) * 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
US5998402A (en) 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
FR2751966B1 (en) * 1996-08-01 1998-10-30 Union Pharma Scient Appl NOVEL 1,2-DIARYLINDOLES, DERIVATIVES THEREOF, AND THERAPEUTIC USES THEREOF
AR016827A1 (en) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL TABLET
US6005102A (en) 1997-10-15 1999-12-21 American Home Products Corporation Aryloxy-alkyl-dialkylamines
US6326392B1 (en) 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
US6069153A (en) * 1998-05-12 2000-05-30 American Home Products Corporation Indenoindoles and benzocarbazoles as estrogenic agents
DE69933212D1 (en) * 1998-05-12 2006-10-26 Wyeth Corp BENZOCARBAZOL AND INDENOINDOLE DERIVATIVES AS ESTROGENE AGENTS
JP2002515431A (en) * 1998-05-15 2002-05-28 アメリカン・ホーム・プロダクツ・コーポレイション 2-Phenyl-1- [4- (2-aminoethoxy) benzyloxy] indole in combination with estrogen
EP1080073A1 (en) * 1998-05-15 2001-03-07 American Home Products Corporation Compositions comprising 2-phenyl-indole compounds and estrogen formulations
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
WO2000050386A1 (en) 1999-02-26 2000-08-31 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CN1342144A (en) * 1999-03-04 2002-03-27 美国家用产品公司 N-substituted benzoyl indoles as estrogenic agents
US6380185B1 (en) 1999-03-04 2002-04-30 American Home Products Corporation N-substituted benzoyl indoles as estrogenic agents
ATE467620T1 (en) 1999-03-26 2010-05-15 Euro Celtique Sa ARYL-SUBSTITUTED PYRAZOLES, IMIDAZOLES, OXAZOLES, THIAZOLES AND PYRROLES, AND THEIR USE
US6159959A (en) * 1999-05-06 2000-12-12 American Home Products Corporation Combined estrogen and antiestrogen therapy
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
NZ517645A (en) * 1999-09-13 2003-09-26 Wyeth Corp Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- [4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
DE19962300A1 (en) * 1999-12-23 2001-06-28 Asta Medica Ag New N-benzylindolyl glyoxylic acid derivatives are useful as antitumor agents
DE10117441A1 (en) * 2001-04-03 2002-10-10 Schering Ag 1-indolyl derivatives, their use in the manufacture of medicaments, a process for the preparation of 1-indolyl derivatives and pharmaceutical preparations containing 1-indolyl derivatives
AU2002317377A1 (en) * 2001-07-20 2003-03-03 Cancer Research Technology Limited Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
MXPA05000898A (en) 2002-07-22 2005-05-16 Lilly Co Eli Selective estrogen receptor modulators containing a phenylsulfonyl group.
GB0224557D0 (en) * 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
EP1689389A4 (en) * 2003-12-04 2009-06-17 Nat Health Research Institutes Indole compounds
JP4879160B2 (en) * 2004-03-16 2012-02-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Palladium-catalyzed indolization of 2-bromo or chloroaniline
DOP2006000016A (en) * 2005-01-26 2006-07-31 Aventis Pharma Inc 2-PHENYL-INDOLES AS ANTAGONISTS OF THE PROSTAGLANDIN RECEPTOR D2.
EP2826475B1 (en) 2007-10-16 2019-03-20 Repros Therapeutics Inc. Trans-clomiphene for treating diabetes in hypogonadal men
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
JP2015508825A (en) 2012-02-29 2015-03-23 レプロス セラピューティクス インコーポレイティド Combination therapy to treat androgen deficiency
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
CN108348605B (en) 2015-11-10 2023-06-09 帕拉卡林治疗公司 Treatment of ER-negative breast cancer with PDGF-CC inhibitors and antiestrogens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3564009A (en) * 1966-01-13 1971-02-16 Sumitomo Chemical Co Process for producing 1-acylindole derivatives
US4543360A (en) * 1981-09-10 1985-09-24 Degussa Aktiengesellschaft 2-(Hydroxy-phenyl)-indoles and process for their production
DE3821148A1 (en) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer AMINO ALKYLINDOLE, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF

Also Published As

Publication number Publication date
AU4271193A (en) 1993-12-13
US5496844A (en) 1996-03-05
EP0639567A4 (en) 1994-12-27
EP0639567A1 (en) 1995-02-22
TW239125B (en) 1995-01-21
WO1993023374A1 (en) 1993-11-25
CA2135160A1 (en) 1993-11-25
AU665690B2 (en) 1996-01-11

Similar Documents

Publication Publication Date Title
KR950701317A (en) Indole Derivative
IL127965A0 (en) Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same
KR950016745A (en) Method of treating physiological symptoms and composition for same
DK0682664T3 (en) Compounds with both potent calcium antagonist and antioxidant activity and their use as cytoprotective agents
ES2193391T3 (en) MUSCARINIC ANTAGONISTS.
UY24935A1 (en) VITRONECTIN RECEPTOR ANTAGONISTS
PL308217A1 (en) Derivatives of 1-(oxo-acetyl)-piperidine-2-carboxylic as agents sensibilising multiple-drug-resistant cancer cells
ES2180530T3 (en) USEFUL THIOPHEN SULFONAMIDS AS CARBON ANHYDRATION INHIBITORS.
ES2133270T3 (en) COMBINATION THERAPY FOR PROPHYLAXIS AND / OR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA.
SE8503680L (en) indole derivatives
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
FR2714378B1 (en) Indol-2-one derivatives substituted in 3 with a nitrogen group, their preparation, pharmaceutical compositions containing them.
FI934274A (en) N-SULPHONYL-2-OXI-INDOLDERIVAT, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
HUP0100388A2 (en) Pharmaceutical compositions and methods for treating osteoporosis and lowering cholesterol
KR950010893A (en) How to suppress endometriosis
ES2101858T3 (en) GENESERINE DERIVATIVES AS CHOLINESTERASE INHIBITORS.
KR950010891A (en) How to treat resistant tumors
MD502G2 (en) New adenozine derivatives, methods of obtainitg thereof, farmaceutical compositions on the base thereof
MX9709451A (en) Benzisoxazole and indazole derivatives as antipsychotic agents.
EA200100140A1 (en) THERAPEUTIC COMPOSITION ON THE BASIS OF FLAVONOIDS FOR APPLICATION IN TREATMENT OF TUMORS BY CYTOTOXIC AGENTS
GEP20043313B (en) Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility
RU94046300A (en) Chemical compounds, method of their synthesis, pharmcomposition, treatment method, intermediate product
DK601583D0 (en) CARBAMYLOXYBENZHYDROLD DERIVATIVES
UY26498A1 (en) SUBSTITUTED PYRROLES
SE9802538D0 (en) New pharmaceutically active compounds

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application